Regarding the function of SEMA3C in breast cancer, our study showed SEMA3C was down-regulated in primary tumours with further reduced expression in the aggressive subtype Her2 and basal-like tumours, indicating a tumour suppressor role of SEMA3C in breast cancer. Here, ERBB2 is linked to neoplasm.